Index Investing News
Saturday, May 31, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower (NASDAQ:INSM)

by Index Investing News
November 26, 2023
in Markets
Reading Time: 2 mins read
A A
0
Home Markets
Share on FacebookShare on Twitter


monsitj

JP Morgan said it was bullish on Insmed (NASDAQ:INSM), Denali (NASDAQ:DNLI), Immunocore (NASDAQ:IMCR), Crinetics (NASDAQ:CRNX), Mirum (NASDAQ:MIRM) and BioCryst (NASDAQ:BCRX), rating all six as overweight in a recent note that reinstated ratings for fifteen large cap biotech stocks.

The investment bank was less keen on Cervel Therapeutics (CERE), Alkermes (ALKS), Novocure (NVCR), Deciphera (DCPH), Stoke (STOK) and Esperion (ESPR), giving those six a neutral rating, and bearish on Amarin (AMRN), Emergent BioSolutions (EBS) and Nektar Therapeutics (NKTR), which were all rated as underweight.

For Insmed, JP Morgan said it expects the stock to “work higher” on the back of recent study updates and ahead of “highly anticipated” data from its ASPEN study of brensocatib in the treatment of non-cystic fibrosis bronchiectasis, which the bank sees as a potential blockbuster opportunity. The ASPEN data is expected in Q2 2024. JP Morgan set its price target for the stock at $36.

Denali shares, meanwhile, could see appreciation ahead of several readouts slated for 2025, in addition to a Phase 2 data for its ALS drug candidate DNL788 expected in the first half of 2024. JP Morgan also sees “multiple avenues for value creation” from the biotech’s pipeline, adding that “we are still in the early innings of the potential value” presented by the company’s BBB-crossing TV platform. The stock’s price target was set at $28.

The investment bank also continues to see upside for Immunocore shares in the wake of a “strong” launch for the oncology drug Kimmtrak. The bank highlighted the potentially “high value pipeline opportunity” with PRAME and a “de-risked” technology platform, setting its price target at $60.

JP Morgan said it sees Crinetics potentially benefitting from several catalysts over the next 12 months, adding it was bullish on the company in the wake of “robust” topline Phase 3 data for its lead candidate paltusotine. Crinetics’ price target was set at $35.

For Mirum, the bank said it sees an “attractive opportunity” for the drug Livmarli “supporting a valuation backstop for the stock” with further potential upside driven by the clinical de-risking of its drug candidate volixibat.

JP Morgan is also bullish on BioCryst, calling the company’s drug Orladeyo a “key value driver for the stock,” with its broad pipeline representing a potential for upside.

More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc.



Source link

Tags: BigBiotechsBullishMorganNASDAQINSMneutralrates
ShareTweetShareShare
Previous Post

8 Holiday Gifts For The Home To Surprise Everyone On Your List This Year

Next Post

Letters to the Editor — Nov. 26, 2023

Related Posts

Can Costco (COST) stay resilient towards tariff headwinds this yr?

Can Costco (COST) stay resilient towards tariff headwinds this yr?

by Index Investing News
May 31, 2025
0

Costco Wholesale Company (NASDAQ: COST) this week reported larger gross sales and revenue for the third quarter, regardless of tariff-related...

This is the reason Jamie Dimon is at all times so gloomy on the financial system

This is the reason Jamie Dimon is at all times so gloomy on the financial system

by Index Investing News
May 31, 2025
0

Jamie Dimon, CEO of JPMorgan Chase, testifies through the Senate Banking, Housing and City Affairs Committee listening to titled Annual...

What to search for when Signet Jewelers (SIG) stories Q1 2026 earnings outcomes

What to search for when Signet Jewelers (SIG) stories Q1 2026 earnings outcomes

by Index Investing News
May 30, 2025
0

Shares of Signet Jewelers Restricted (NYSE: SIG) have been down 1% on Friday. The inventory has gained 26% over the...

Did a Secret Courtroom Simply Halt Trump’s Tariffs?

Did a Secret Courtroom Simply Halt Trump’s Tariffs?

by Index Investing News
May 30, 2025
0

Final Friday, I walked out of the grocery retailer shaking my head. I had simply picked up a bottle of...

What a federal commerce courtroom block on Trump tariffs means for shoppers

What a federal commerce courtroom block on Trump tariffs means for shoppers

by Index Investing News
May 30, 2025
0

President Donald Trump holds a chart as he proclaims a plan for tariffs on imported items throughout an occasion April...

Next Post
Letters to the Editor — Nov. 26, 2023

Letters to the Editor — Nov. 26, 2023

His Parkinson’s Disease Battle Explained – Hollywood Life

His Parkinson’s Disease Battle Explained – Hollywood Life

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Microsoft says early June service outages were cyberattacks By Reuters

Microsoft says early June service outages were cyberattacks By Reuters

June 18, 2023
49ers not fearing long-term Brock Purdy absence

49ers not fearing long-term Brock Purdy absence

November 24, 2024
How To Buy Quality Over Quantity And The Financial Pros of Doing So!

How To Buy Quality Over Quantity And The Financial Pros of Doing So!

January 9, 2023
Tesla Inc (TSLA) Q4 2023 Earnings Call Transcript

Tesla Inc (TSLA) Q4 2023 Earnings Call Transcript

March 6, 2023
American exceptionalism needs to change by 2030

American exceptionalism needs to change by 2030

April 11, 2023
Seattle’s growth is heating up the region — literally. See where

Seattle’s growth is heating up the region — literally. See where

August 6, 2023
NAR Hit w/ One other Blow After Stunning “Donation” Discovery

NAR Hit w/ One other Blow After Stunning “Donation” Discovery

December 12, 2024
Court strikes blow to Biden’s student debt scheme — RT World News

Court strikes blow to Biden’s student debt scheme — RT World News

December 1, 2022
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In